Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-04-06
Original SEC Filing: Click here

---

Webplus: SVA/20120406/6-K/2_EX-99.1/000.htm SEC Original: v301323_ex99-1.htm
Sinovac Announces Director Appointment BEIJING, March 29, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Meng Mei as an independent director to fill the vacancy created by the resignation of Ms. Chup Hung Mok. Mr. Mei has also been appointed as the chairman of Sinovac’s compensation

---

---

Webplus: SVA/20120406/6-K/3_EX-99.2/000.htm SEC Original: v301323_ex99-2.htm
Sinovac’s EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine Vaccine BEIJING, March 29, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that the positive Phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and

---

---

Webplus: SVA/20120406/6-K/1/000.htm SEC Original: v301323_6k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-04-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085